The diabetes management technology market has seen large shifts over the last few years. At the centre of this has been the Continuous Glucose Monitor (CGM) industry, with CGM giant Dexcom reporting a 237% revenue increase between 2018-2021 to reach $2.45bn by the end of 2021. This has contributed to declines in the billion-dollar test strip industry; by the year 2032, IDTechEx predicts the test strip industry to make up only 6.7% of the overall diabetes management device market, down from a peak of 63.4% in 2010. However, the effects of CGMs will not be limited to just the glucose sensor industry; CGMs will affect the entire diabetes management technology market, with particularly large effects in digital health and insulin delivery industries.
IDTechEx forecasts the total CGM industry to exceed $15 billion by 2032. This webinar will discuss the wider implications of CGMs on the overall diabetes management technology industry. This webinar includes:
- Discussions on how CGMs can drive diabetes management digital health platforms,
- An overview on how a growing CGM industry will affect the insulin delivery industry,
- Future targets of the diabetes management technology industry and several examples of technologies being developed to meet these targets.
This webinar is based on IDTechEx's latest detailed technical market report "Diabetes Management Technologies 2022-2032: Markets, Players, and Forecasts
", which provides a comprehensive overview of the entire diabetes management technology market. Using a combination of primary interviews and secondary research, IDTechEx provides detailed analyses and market outlooks across a range of industries. This report offers relevant current information from both technical and commercial points of view, along with insights into this rapidly evolving industry.